New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

Immuno-Oncology 360°

IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.